Novartis Faces Legal Battle Over Alleged Improper Promotion of Asthma Drug for Preterm Labor Risks
In a legal skirmish unfolding against Swiss pharmaceutical giant Novartis, accusations fly thick and fast regarding the illicit promotion of an asthma drug for treating preterm labor, despite glaring risks of fetal brain abnormalities.…
